Matches in Wikidata for { <http://www.wikidata.org/entity/Q100424881> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q100424881 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100424881 description "scientific article published on 02 October 2020" @default.
- Q100424881 description "wetenschappelijk artikel" @default.
- Q100424881 description "наукова стаття, опублікована 2 жовтня 2020" @default.
- Q100424881 name "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 name "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 name "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 type Item @default.
- Q100424881 label "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 label "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 label "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 prefLabel "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 prefLabel "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 prefLabel "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 P1433 Q100424881-EAD9EF54-E144-4A4E-B4BD-F40F310F6B13 @default.
- Q100424881 P1476 Q100424881-194393A6-88C5-4B82-8C7F-95536A0C1017 @default.
- Q100424881 P2093 Q100424881-291A614B-7D93-46AB-BE73-A55A660208AB @default.
- Q100424881 P2093 Q100424881-31D0E713-2E79-4752-807A-6A40E350FC56 @default.
- Q100424881 P2093 Q100424881-450E7129-E296-453E-9E6E-BA2D48109854 @default.
- Q100424881 P2093 Q100424881-7C0034E1-4FE5-4B7D-B76A-C8FD0897292B @default.
- Q100424881 P2093 Q100424881-9BF12906-0464-4C7C-A9E6-F95911678378 @default.
- Q100424881 P2093 Q100424881-CFA672D2-F6D1-4041-BE07-F80A2F06ED36 @default.
- Q100424881 P304 Q100424881-FE9E6AE2-8037-43B9-ACE8-2C5A965BB4D5 @default.
- Q100424881 P31 Q100424881-1F9D8E51-AFEF-40E6-B9C6-26F0C950DF52 @default.
- Q100424881 P356 Q100424881-54147788-A3A6-40B7-B39F-FE5E43BDE0F7 @default.
- Q100424881 P433 Q100424881-805E9E97-FD85-44A1-9B68-68F2E2A13911 @default.
- Q100424881 P478 Q100424881-501D6D6D-0D88-4649-BDB1-6184D6371D98 @default.
- Q100424881 P50 Q100424881-62409C6D-812E-4BFD-AD48-EF5008C90B3D @default.
- Q100424881 P577 Q100424881-0FAEC9B4-2F58-471B-BE1F-AB2FBA9050EE @default.
- Q100424881 P698 Q100424881-34CCF3CA-315F-489F-9673-FDAB451990AE @default.
- Q100424881 P356 S12885-020-07424-W @default.
- Q100424881 P698 33008313 @default.
- Q100424881 P1433 Q326300 @default.
- Q100424881 P1476 "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations" @default.
- Q100424881 P2093 "Go Naka" @default.
- Q100424881 P2093 "Haruhito Sugiyama" @default.
- Q100424881 P2093 "Manabu Suzuki" @default.
- Q100424881 P2093 "Masao Hashimoto" @default.
- Q100424881 P2093 "Shinyu Izumi" @default.
- Q100424881 P2093 "Yoh Yamaguchi" @default.
- Q100424881 P304 "951" @default.
- Q100424881 P31 Q13442814 @default.
- Q100424881 P356 "10.1186/S12885-020-07424-W" @default.
- Q100424881 P433 "1" @default.
- Q100424881 P478 "20" @default.
- Q100424881 P50 Q92288088 @default.
- Q100424881 P577 "2020-10-02T00:00:00Z" @default.
- Q100424881 P698 "33008313" @default.